Improving immunotherapy for solid tumors like melanoma.
Outreach Core
['FUNDING_OTHER'] · INSTITUTE FOR SYSTEMS BIOLOGY · NIH-10916312
This study is looking at how to make cancer treatments work better for people with melanoma by combining immunotherapy with other targeted therapies, while also helping students from diverse backgrounds learn about cancer research and personalized medicine through hands-on experiences.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INSTITUTE FOR SYSTEMS BIOLOGY (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10916312 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the effectiveness of immunotherapy combined with targeted inhibitors for treating solid tumors, particularly melanoma. It employs a systems biology approach, integrating experimental and computational methods to optimize treatment strategies. The program also includes an outreach component aimed at educating and engaging underrepresented student populations in STEM fields through hands-on experiences in immuno-oncology. By collaborating with students, researchers aim to develop educational modules that incorporate advanced concepts in personalized medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with solid tumors, especially melanoma, who may benefit from advanced immunotherapy treatments.
Not a fit: Patients with non-solid tumors or those who do not respond to immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with solid tumors, improving their chances of recovery.
How similar studies have performed: Previous research has shown promise in combining immunotherapy with targeted treatments, indicating potential for success in this approach.
Where this research is happening
SEATTLE, UNITED STATES
- INSTITUTE FOR SYSTEMS BIOLOGY — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LUDWIG, CLAUDIA — INSTITUTE FOR SYSTEMS BIOLOGY
- Study coordinator: LUDWIG, CLAUDIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.